Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
BIODELIVERY SCIENCES INTERNATIONAL INC
| Metric | BIODELIVERY SCIENCES INTERNATIONAL INC Healthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $167M |
| Net income (latest) | $85M |
| Operating margin | 22.3% |
| Net margin | 50.9% |
| Return on equity | 45.2% |
| Return on assets | 26.1% |
| Return on capital (ROCE) | 15.3% |
| Debt / equity | 0.73× |
| Revenue growth (YoY) | 6.5% |
| Altman Z″ (distress) | 2.06 |
| Accruals / assets | 13.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.